InvestorsHub Logo
Followers 52
Posts 9089
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Thursday, 05/04/2023 12:12:42 AM

Thursday, May 04, 2023 12:12:42 AM

Post# of 13459
Moderna Announces Phase 1/2 Data on mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA) to be Presented at the 2023 ASGCT Annual Meeting


https://investors.modernatx.com/news/news-details/2023/Moderna-Announces-Phase-12-Data-on-mRNA-3927-an-Investigational-mRNA-Therapy-for-Propionic-Acidemia-PA-to-be-Presented-at-the-2023-ASGCT-Annual-Meeting/default.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News